Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FT.4ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
FT.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
FT.4SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
FT.4SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
FT.4SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
XALORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XALORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
XALORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
XALORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
XALORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
XALORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
XALORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XALORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
XALORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XALSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XALSChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
XALSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XALEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XALECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XALEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XALENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XALNCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
XALNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XALNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XALNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XALNUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XALNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XALNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XALNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XALNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XALNHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XALNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XALNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XALORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
XALORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
XALORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XALSWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
XALSNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
XALSNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
XBWORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XBWORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
XBWORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
XBWORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
XBWORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
XBWORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
XBWORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBWORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
XBWORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XBWSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBWSChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used